АНТИФОСФОЛИПИДНЫЕ АНТИТЕЛА У ПАЦИЕНТОВ С НОВОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИЕЙ

Библиографические ссылки:

Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.https://doi.org/10.1056/NEJMoa2002032

Ying-Kiat Tan, Claire Goh, Aloysius S T Leow, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct; 50(3): 587-595.https://doi.org/10.1007/s11239-020-02228-y

Arne Vandevelde, Walid Chayoua, Bas de Laat. Anticoagulant/Antiphospholipid Antibodies. J Thromb Haemost. 2022 Sep; 20(9): 2136-2150. https://doi.org/10.1111/jth.15785.

Edgar Gracia-Ramos, Eduardo Martin-Nares, Gabriela Hernández-Molina. New Onset of Autoimmune Diseases Following COVID-19. Diagnosis Abraham Cells. 2021 Dec 20; 10(12): 3592.https://doi.org/10.3390/cells10123592.

Katja Lakota, Katja Perdan-Pirkmaje, Alojzija Hočevar. COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases. Front Immunol. 2021 Jan 26; 11: 611318.https://doi.org/10.3389/fimmu.. 2020.611318.

Tan Y.K., Goh C., Leow A.S.T., Tambyah P.A., Ang A., Yap E.S., Tu T.M., Sharma V.K., Yeo L.L.L., Chan B.P.L., Tan B.Y.Q. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct; 50(3): 587-595.https://doi.org/10.1007/s11239-020-02228-y.PMID..

Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. 2021 Jul; 40(7): 2611-2619.https://doi.org/10.1007/s10067-021-05691-x..

Samy Metyas, Christina Chen, Tun Aung. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series. Curr Rheumatol Rev. 2022; 18(4): 346-351.https://doi.org/10.2174/1573397118666220211155716.

Arad Dotan, Sylviane Muller, Darja Kanduc, Paula David, Gilad Halpert, Yehuda Shoenfeld. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021 Apr; 20(4): 102792.https://doi.org/10.1016/j.autrev.2021.102792

Tessa Noordermeer, Roger E.G. Schutgens, Chantal Visser, et al. Lupus anticoagulant causes thrombosis in COVID-19 patients admitted to intensive care units: a retrospective cohort study. Res Pract Thromb Haemost. 2022 Sep 16; 6(6): e12809.https://doi.org/10.1002/rth2.12809

Hiroyuki Fujii, Taisuke Tsuji, Tatsuya Yuba, Shunya Tanaka. High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: High levels of anti-SSA/Ro antibodies in COVID-19. Clin Rheumatol. 2020 Nov; 39(11): 3171-3175.https://doi.org/10.1007/s10067-020-05359-y

Francisco Javier Gil-Etayo, Sara Garcinuño, Antonio Lalueza. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines. 2021 Jul 27; 9(8): 899.https://doi.org/10.3390/biomedicines9080899

Mariam Ahmed Saad, Mostafa Alfishawy, Mahmoud Nassar et al. COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases. Curr Rheumatol Rev. 2021; 1717(2): 193204.https://doi.org/10.2174/157339711666620102915585.

Iverson G.M., Reddel S., Victoria E.J. et al. Use of single point mutations in domain I of beta2-glycoprotein I to determine fine anticenic specificity of antiphospholipid autoantibodies. J Immunol. 2002; 169: 7097-103.https://doi.org/10.4049/jimmunol.169.12.7097

Hussin A Rothan, Siddappa N Byrareddy. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020; 109: 102433.https://doi.org/10.1016/j.jaut.2020.102433

Miyakis S., Lockshin M., Atsumi T. et al. International consensus statement on an update of the classification criteria for definite anthiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4: 295-306.https://doi.org/10.1111/j.1538-7836.2006.01753.x

Кобилянская В.А. Определение волчаночного антикоагулянта у пациентов на фоне приема ривароксабана. Вестник гематологии. 2018; XIV(3): 47-48.

Vorobjeva N.V. Neutrophil Extracellular Traps: New Aspects. Moscow Univ Biol Sci Bull. 2020.https://doi.org/10.3103/S0096392520040112

Tripodi A., Moia M., Pengo V. False-negative and false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: a rebuttal. J Thromb Haemost. 2011; 9: 1435.https://doi.org/10.1111/j.1538-7836.2011.04284.x

Anahita Nosrati, Zhila Torabizadeh, Donya Heirkhah. Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy. Tanaffos. 2022 Jan; 21(1): 45-53.

Virginie Siguret, Sebastian Voicu, Marie Neuwirth. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Thromb Res. 2020 Nov; 195: 74-76.https://doi.org/10.1016/j.thromres.2020.07.016

Thomas Foret, Virginie Dufrost, Lucie Salomon Du Mont. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders? Curr Rheumatol Rep. 2021 Jul 3; 23(8): 65.https://doi.org/10.1007/s11926-021-01029-3.24.

Yu Zuo, Shaneya K Estes, Ramadan Ali, Alex A. Gandhi et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020 Nov 18; 12(570): eabd3876.https://doi.org/10.1126/scitranslmed.abd3876

Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi. Is lupus anticoagulant an important symptom of COVID-19? Critical evaluation of literature. Res Pract Thromb Haemost. 2022 Sep 16; 6(6): e12809.https://doi.org/10.1002/rth2.12809.

Levi M., Thachil J., Iba T., Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; 7: e438-e440.https://doi.org/10.1016/S2352-3026(20)30145-9..

Папаян Л.П., Капустин С.И., Шмелева В.М., Кобилянская В.А. Тромбофилии. Врожденные и приобретенные нарушения в системе гемостаза, предрасполагающие к развитию тромбоза // глава в кн. «Рациональная фармакотерапия в гематологии» под ред. О.А. Рукавицына. Москва: Литтера, 2021; 15-28.

Матвиенко О.Ю., Корсакова Н.Е., Шведова Т.Н., Гуржий А.А., Папаян Л.П. Состояние плазменного звена гемостаза у пациентов с коронавирусной инфекцией, вызванной вирусом SARS-CоV-2. Тромбоз, гемостаз и реология. 2020; 4: 52-56.

Soohyun Woo, Bohyun Kim, Nam Hong Ho, Min Sung Kim. Association of Lupus Anticoagulant Status with Disease Course in SARS-CoV-2 (COVID-19) Infection. Clin Appl Thromb Hemost. 2022 Jan-Dec; 28.https://doi.org/10.1177/10760296221127276

Carmine Gazzaruso, Giuseppe Mariani, Carolina Ravetto. Lupus anticoagulant and mortality in patients hospitalized for COVID-19. J Thromb Thrombolysis. 2021 Jul; 52(1): 85-91.https://doi.org/10.1007/s11239-020-02335-w..

Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L'Andolina. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 2020 Nov; 39(11): 3195-3204.https://doi.org/10.1007/s10067-020-05334-7..

Meng Xiao, Yan Zhang, Shulan Zhang, Xuzhen Qin. Antiphospholipid antibodies in critically ill patients with COVID-19. Arthritis Rheumatol. 2020 Dec; 72(12): 1998-2004.https://doi.org/10.1002/art.41425..

Swadzba J., Iwaniec T., Pulka M. et al. Lupus anticoagulant: perfomans of the tests as recommended by the latest ISTH guidelines. J Thromb Haemost. 2011; 9: 1776-83.

Catherine M.J. Devries, Eleni A. Linsken, Dominique Benoist et al. Antiphospholipid antibodies in patients with COVID-19: a current observation? J Thromb Haemost. 2020 Sep; 18(9): 2191-2201.https://doi.org/10.1111/jth.14994.

Nikolopoulou G.B., Maltezou H.C. COVID-19 in Children: Where do we Stand? Arch Med Res. 2022 Jan; 53(1): 1-8.https://doi.org/10.1016/j.arcmed.2021.07.002.. PMID: 34311990.

Ying Sun, Yawen Zou, Haiyu Wang. Immune response induced by novel coronavirus infection. Review Front Cell Infect Microbiol. 2022 Oct. 25; 12: 988604.https://doi.org/10.3389/fcimb.2022.988604.

Rebecca Borella, Sara De Biasi, Annamaria Paolini et al. Metabolic reprograming shapes neutrophil functions in severe COVID-19. Eur J Immunol. 2022 Mar; 52(3): 484-502.https://doi.org/10.1002/eji.202149481.

Матвиенко О.Ю., Головина О.Г., Кобилянская В.А., Смирнова О.А., Папаян Л.П. Состояние системы гемостаза у пациентов, перенесших новую коронавирусную инфекцию. Эффективность антикоагулянтной профилактики. Бюллетень медицинской науки. 2022; 3(27): 30-37.https://doi.org/10.31684/25418475_2022_3_30

Lin J.E., Asfour A., Sewell T.B., Hooe B., Pryce P., Earley C. et al. Neurological issues in children with COVID-19. Neurosci Lett. 2021 Jan 19; 743: 135567.https://doi.org/10.1016/j.neulet.2020.135567.. PMID: 33352286.

Monica Galli, Davide Luciani, Guido Bertolini, Tiziano Barbui. Anti-beta2-glycoprotein I, antiprotrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003; 102(8); 2717-23.https://doi.org/10.1182/blood-2002-11-3334

Ebeling F., Petterson T., Muukkonen L. et al. Beta2-glycoprotein I antibodies in patients with thrombosis. Scand J Clin Lab Invest. 2003; 63(2): 111-8.https://doi.org/10.1080/00365510310002086

Maria C Sacchi, Stefania Tamiazzo, Paolo Stobbione, Lisa Agatea. SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci. 2021 May; 14(3): 898-907.https://doi.org/10.1111/cts.12953

Maria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome. Arthritis Rheumatol. 2021 Nov; 73(11): 1976-1985. https://doi.org/10.1002/art.41777.. 27.

Thiviya Darmarajan, Keshav Raj Paudel, Mayuren Candasamy. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation. Environ Sci Pollut Res Int. 2022 Aug; 29(36): 54072-54087.https://doi.org/10.1007/s11356-022-20984-7

Amer Hamadé, Bastien Woehl, Ines Harzallah. Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit. Blood Coagul Fibrinolysis. 2021 Mar 1; 32(2): 73-79. https://doi.org/10.1097/MBC.0000000000000963.

Tomislav Brblić, Klara Brčić, Sandra Margetić. Lupus anticoagulant-hypoprothrombinemia syndrome with severe bleeding diathesis after coronavirus disease 2019: a case report. Croat Med J. 2022 Oct 31; 63(5): 490-494. https://doi.org/10.3325/cmj.2022.63.490.

Gisela Garcia-Arellano, Adrian Camacho-Ortiz, Ilse Andrea Moreno-Arquieta et al. Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19. Am J Med Sci. 2023 Feb; 365(2): 215-217.https://doi.org/10.1016/j.amjms.2022.10.012

Arcanjo A., Logullo J., Menezes C.C.B., de Souza Carvalho Giangiarulo T.C. et al. The emerging role ofneutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci Rep. 2020 Nov12; 10(1): 19630.https://doi.org/10.1038/s41598-020-76781-0.. PMID: 33184506.

Hui Zeng, Meihong Cai, Han Xue, Wen Xie, Xinghua Li. Prevalence and coagulation correlation of anticardiolipin antibodies in patients with COVID-19. Medicine (Baltimore). 2022 Oct 14; 101(41): e31040.https://doi.org/10.1097/MD.0000000000031040

Sami Hossri, Mahmoud Shadi, Zaid Hamarsha. Clinically significant anticardiolipin antibodies associated with COVID-19. J Crit Care. 2020 Oct; 59: 32-34.https://doi.org/10.1016/j.jcrc.2020.05.017.

Kalyanaraman M., Anderson M.R. COVID-19 in Children. Pediatr Clin North Am. 2022 Jun; 69(3): 547-571.https://doi.org/10.1016/j.pcl.2022.01.013..

Toglu M.A., Pektezel M.Y., Oge D.D., Bulut Yüksel N.D. et all. Stroke Mechanism in COVID-19 Infection: A Prospective Case-Control Study. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8): 105919.https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105919

Antonella Capozzi, Gloria Riitano, Serena Recalchi. Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation. Front Immunolog. 2023 Mar 2; 14: 1129201.https://doi.org/10.3389/fimmu.2023.1129201..